Table 1.

Examples of spectral components that differentiated serum samples collected after surgery and one year after the end of basic therapy.

			q-value of the difference
Component m/z	Hypothetical identity	Δ	All patients	Adjuvant therapy	Only surgery
2,742			0.050	0.118	0.275
3,263	FGA (fr.576-604)	I	0.053	0.084	0.506
3,302	-	I	0.039	0.238	0.150
3,992	-	D	0.039	0.136	0.182
4,038	-	I	0.099	0.099	0.510
4,524	APP (fr.672-713)	D	0.053	0.084	0.462
4,642	-	D	0.049	0.201	0.157
4,713	-	I	0.038	0.199	0.152
5,048	-	I	0.025	0.081	0.262
5,067	-	I	0.038	0.084	0.367
5,377	-	D	0.053	0.016	0.344
5,403	-	D	0.159	0.016	0.181
5,877	FGA (fr.581-633)	D	0.039	0.084	0.238
5,998	-	D	0.076	0.084	0.344
6,489	-	D	0.038	0.084	0.272
6,939	TTR (fr.21-147)	I	0.001	0.016	0.119
8,032	-	D	0.037	0.090	0.193
8,095	-	D	0.038	0.128	0.137
8,156	-	D	0.039	0.201	0.150
8,354	C3 (fr.672-739)	D	0.038	0.238	0.101
8,844	-	D	0.053	0.086	0.251
8,888	VTN (fr.402-478)	D	0.039	0.206	0.152
8,931	C3 (fr.672-747)	D	0.039	0.238	0.106
8,942	APOA2 (fr.24-100)	D	0.024	0.084	0.204
8,973	-	D	0.024	0.099	0.193
9,419	APOC3 (fr.21-99)	I	0.024	0.084	0.207
9,519	-	D	0.039	0.207	0.150
9,990	-	D	0.099	0.081	0.333
12,359	-	D	0.038	0.238	0.151
12,453	-	D	0.048	0.154	0.244

Shown are: approximate m/z value, hypothetical identity, average change in abundance between samples B and C (D - decrease, I - increase) and q-value of the difference (the Storey test). Components that differentiated samples B and C both in group of all patients and patients subjected to adjuvant therapy are underlined.